Otsuka Pharmaceutical, Inc., Philippines
Quick facts
Marketed products
- Rebamipide and Esomeprazole · Gastroenterology
This combination product uses rebamipide to protect and promote gastric mucosa healing while esomeprazole reduces gastric acid secretion to treat acid-related disorders.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: